These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7902708)
1. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys). Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708 [TBL] [Abstract][Full Text] [Related]
2. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism. Higuchi S; Muramatsu T; Murayama M; Hayashida M Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of the dopamine D2 receptor gene]. Arinami T; Itokawa M Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):129-37. PubMed ID: 7941777 [TBL] [Abstract][Full Text] [Related]
4. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia. Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079 [TBL] [Abstract][Full Text] [Related]
5. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049 [TBL] [Abstract][Full Text] [Related]
6. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients. Chen CH; Chien SH; Hwu HG Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714 [TBL] [Abstract][Full Text] [Related]
7. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia. Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271 [TBL] [Abstract][Full Text] [Related]
8. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Shaikh S; Gill M; Owen M; Asherson P; McGuffin P; Nanko S; Murray RM; Collier DA Am J Med Genet; 1994 Mar; 54(1):8-11. PubMed ID: 8178839 [TBL] [Abstract][Full Text] [Related]
9. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia. Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166 [TBL] [Abstract][Full Text] [Related]
10. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Gaitonde EJ; Morris A; Sivagnanasundaram S; McKenna PJ; Hunt DM; Mollon JD Am J Med Genet; 1996 Sep; 67(5):455-8. PubMed ID: 8886161 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia. Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285 [TBL] [Abstract][Full Text] [Related]
12. Association study between schizophrenia and dopamine D3 receptor gene polymorphism. Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704 [TBL] [Abstract][Full Text] [Related]
14. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Weiss J; Mägert HJ; Cieslak A; Forssmann WG Eur J Med Res; 1996 Jun; 1(9):439-45. PubMed ID: 9353244 [TBL] [Abstract][Full Text] [Related]
15. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms. Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577 [TBL] [Abstract][Full Text] [Related]
16. Search for mutations in the beta 1 GABAA receptor subunit gene in patients with schizophrenia. Coon H; Sobell J; Heston L; Sommer S; Hoff M; Holik J; Umar F; Robertson M; Reimherr F; Wender P Am J Med Genet; 1994 Mar; 54(1):12-20. PubMed ID: 8178835 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
18. Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. Ram A; Cao Q; Keck PE; Pope HG; Otani K; Addonizio G; McElroy SL; Kaneko S; Redlichova M; Gershon ES Am J Med Genet; 1995 Jun; 60(3):228-30. PubMed ID: 7573176 [TBL] [Abstract][Full Text] [Related]
19. Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history of schizophrenia? Nimgaonkar VL; Zhang XR; Caldwell JG; Ganguli R; Chakravarti A Am J Med Genet; 1993 Dec; 48(4):214-7. PubMed ID: 8135304 [TBL] [Abstract][Full Text] [Related]
20. Association study of dopamine D3 receptor gene and schizophrenia. Kennedy JL; Billett EA; Macciardi FM; Verga M; Parsons TJ; Meltzer HY; Lieberman J; Buchanan JA Am J Med Genet; 1995 Dec; 60(6):558-62. PubMed ID: 8825896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]